We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHIL
201
DELISTED
Diamond Hill
DHIL
– –
-7,404
Closed -$1.2M
DOW icon
202
Dow Inc
DOW
$20.8B
– –
-4,140
Closed -$226K
DT icon
203
Dynatrace
DT
$12.7B
– –
-20,722
Closed -$1.11M
DVA icon
204
DaVita
DVA
$15.2B
– –
-2,472
Closed -$405K
DXCM icon
205
DexCom
DXCM
$28.3B
– –
-7,391
Closed -$495K
EAT icon
206
Brinker International
EAT
$8.38B
– –
-4,987
Closed -$382K
ED icon
207
Consolidated Edison
ED
$41.1B
– –
-10,098
Closed -$1.05M
EHC icon
208
Encompass Health
EHC
$11.3B
– –
-3,440
Closed -$332K
EL icon
209
Estee Lauder
EL
$30.1B
– –
-6,912
Closed -$689K
ELAN icon
210
Elanco Animal Health
ELAN
$12.7B
– –
-43,127
Closed -$634K
ENSG icon
211
The Ensign Group
ENSG
$10.4B
– –
-1,927
Closed -$277K
ESAB icon
212
ESAB
ESAB
$5.49B
– –
-8,056
Closed -$856K
ESE icon
213
ESCO Technologies
ESE
$8.4B
– –
-6,044
Closed -$780K
EVER icon
214
EverQuote
EVER
$929M
– –
-29,712
Closed -$627K
EVTC icon
215
Evertec
EVTC
$1.88B
– –
-21,941
Closed -$744K
EW icon
216
Edwards Lifesciences
EW
$47.8B
– –
-10,332
Closed -$682K
EXAS
217
DELISTED
Exact Sciences
EXAS
– –
-20,341
Closed -$1.39M
EYE icon
218
National Vision
EYE
$1.66B
– –
-90,091
Closed -$983K
FBNC icon
219
First Bancorp
FBNC
$2.59B
– –
-38,451
Closed -$1.6M
FF icon
220
Future Fuel
FF
$203M
– –
-68,916
Closed -$396K
FLGT icon
221
Fulgent Genetics
FLGT
$556M
– –
-21,690
Closed -$471K
FLYW icon
222
Flywire
FLYW
$1.99B
– –
-12,001
Closed -$197K
FMC icon
223
FMC
FMC
$1.39B
– –
-7,775
Closed -$513K
FNF icon
224
Fidelity National Financial
FNF
$14B
– –
-6,223
Closed -$386K
FOLD
225
DELISTED
Amicus Therapeutics
FOLD
– –
-21,723
Closed -$232K
7 8
9
10 11

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.